Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Federico Rodriguez-Porcel*, Kathryn A. Wyman-Chick, Carla Abdelnour Ruiz, Jon B. Toledo, Daniel Ferreira, Prabitha Urwyler, Rimona S. Weil, Joseph Kane, Andrea Pilotto, Arvid Rongve, Bradley Boeve, John Paul Taylor, Ian McKeith, Dag Aarsland, Simon J.G. Lewis, the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

3 Downloads (Pure)

Abstract

Following publication of the original article [1], the authors identified some errors in the Additional files 1–5. The original article [1] has been corrected.

Original languageEnglish
Article number29
JournalTranslational Neurodegeneration
Volume11
DOIs
Publication statusPublished - 17 May 2022

ASJC Scopus subject areas

  • Clinical Neurology
  • Cognitive Neuroscience
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations'. Together they form a unique fingerprint.

Cite this